Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly.

Borre, M

Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly. [electronic resource] - Prostate cancer and prostatic diseases Sep 1998 - 268-275 p. digital

Publication Type: Journal Article

1476-5608

10.1038/sj.pcan.4500252 doi